Viewing nowCombinationTenelia M Sustained-release Tablet 10/500 mg
Metformin Hydrochloride 500mg · Teneligliptin Hydrobromide Hydrate 15.5mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.

MFDS item code 201501699 · Approved 2015.03.31 · Insurance code 652105460
Improvement of blood glucose control in type 2 diabetes
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It particularly helps to manage blood sugar levels more effectively by administering Teneligliptin and Metformin together. Taking this medication stabilizes blood sugar levels, significantly aiding in the management of diabetes. It supports patients in reducing blood sugar fluctuations in daily life. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, dose reduction of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switched to it from other glucose-lowering agents. Since such a change may result in changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing.
This medication aids in controlling blood sugar, but a rare side effect known as severe lactic acidosis may occur in some patients. This side effect can be particularly risky for those with impaired kidney function or those with heart disease, sepsis, etc. This medication should not be given to patients with moderate to severe impairment of kidney function, heart failure, acute myocardial infarction, or sepsis. Additionally, the use of this medication should be temporarily suspended before and after examinations using iodinated contrast agents, and patients with liver dysfunction or pregnant women should avoid its use. When used in conjunction with other medications for diabetes treatment, the risk of hypoglycemia may increase, so patients should be well-informed about the symptoms of hypoglycemia and may need to adjust dosages of other medications as necessary. During treatment, kidney function and liver function should be regularly monitored to ensure there are no abnormalities, and vitamin B12 levels may decrease, so monitoring is advisable. During this medication, dehydration, severe vomiting or diarrhea, acute infections, and before and after surgery should lead to temporary discontinuation of its use, and if sudden abdominal pain or vomiting occurs, which may suggest pancreatitis, immediate consultation with healthcare professionals is necessary. Alcohol consumption may increase the risk of lactic acidosis, so it is important not to overindulge during treatment. Particularly, caution is needed for the elderly or those with reduced kidney function, and patients and families should be adequately informed of symptoms of hypoglycemia or lactic acidosis that may occur with this medication. Finally, this medication has not established safety and efficacy in children, so it is advisable not to use it.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius to preserve the medication's effectiveness for a long time.
Orange egg-shaped sustained-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Teneligliptin Hydrobromide Hydrate 15.5mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
CombinationMetformin Hydrochloride 750mg · Teneligliptin Hydrobromide Hydrate 15.5mg
Tablet · Prescription medication · Combination
HanDoc Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Teneligliptin Hydrobromide Hydrate 31mg
Tablet · Prescription medication · Combination
Handok Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.